Form 4: Aptevo Therapeutics Inc. Executive Kwon SoYoung Reports Stock Transactions
SEC Form 4 Filing
SVP, GC, BD & Corp Affairs Kwon SoYoung reports acquisition of Aptevo Therapeutics Inc. common stock through RSU conversion.
Summary
- On March 2, 2024, Kwon SoYoung, SVP, GC, BD & Corp Affairs of Aptevo Therapeutics Inc., acquired 3,667 shares of common stock through the conversion of Restricted Stock Units (RSUs).
- Following this transaction, Kwon SoYoung directly owns 20,375 shares of Aptevo Therapeutics Inc. common stock.
- On March 3, 2024, Kwon SoYoung acquired another 3,667 shares of common stock through RSU conversion.
- Following this transaction, Kwon SoYoung directly owns 24,042 shares of Aptevo Therapeutics Inc. common stock.
- The RSUs convert into common stock on a one-for-one basis.
- The reported transactions were executed under previously granted RSU awards.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports routine stock transactions related to RSU vesting. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The acquisition of shares by an executive could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Comparison to Industry Standards
- Tracking insider transactions is a common practice in financial analysis.
- Analysts often compare insider activity to historical patterns and industry peers to gauge sentiment.
- However, without additional context, it's difficult to determine if these transactions are significant compared to industry benchmarks.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 06/07/2022 | Reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023. |
| 03/03/2023 | Reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024. |
| 03/02/2024 | Kwon SoYoung acquired 3,667 shares of common stock through RSU conversion. |
| 03/03/2024 | Kwon SoYoung acquired 3,667 shares of common stock through RSU conversion. |
| 03/05/2024 | Date of Form 4 filing. |
Keywords
Form 4, Aptevo Therapeutics Inc., APVO, Kwon SoYoung, Restricted Stock Units, RSU, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.